Department of Biochemistry, Faculty of Science, Kasetsart University, Bangkok, 10900, Thailand.
Department of Biochemistry, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
Mol Cell Biochem. 2021 Apr;476(4):1663-1672. doi: 10.1007/s11010-020-04045-6. Epub 2021 Jan 9.
Nasopharyngeal carcinoma (NPC) is one of the rare cancers in western countries but predominant in Southeast Asian countries including Thailand. One major cause for failure of NPC chemotherapeutic treatments is reportedly correlated with the elevation of cancer stem cell (CSC) fractions. Thus, this present study aims to investigate the effect of cisplatin (CDDP) treatment on the enrichment of cancer stem-like cells (CSCs) and its associated signaling pathway in EBV-negative NPC cells. Cisplatin-pretreated 5-8F NPC cells (5-8F CDDP) were first generated by treating the cells with 0.5 μM cisplatin for 48 h. After the instant treatment, 5-8F CDDP showed increased IC values, demonstrating a decrease in CDDP sensitization. Besides, the proportion of NPC cells with cancer stem-like phenotypes comprising side population (SP), key stemness-related gene expressions including SOX2, ALDH1, CD24 was significantly enhanced. Additionally, 5-8F CDDP displayed the upregulation of β-catenin gene, suggesting its association with the CSC-initiating mechanism. Furthermore, a tankyrase inhibitor for Wnt/β-catenin pathway, XAV939, substantially reduced CSCs and retrieved the cisplatin sensitivity in 5-8F CDDP. This confirms that the Wnt/β-catenin signaling is accountable for rising of the CSC population in EBV-negative NPC. Finally, the combined treatment of CDDP and XAV939 exhibited lower 5-8F CDDP cell viability compared to the treatment of CDDP alone, suggesting the reversal of cisplatin sensitization. In conclusion, the enhancement of CSCs in 5-8F NPC cells caused by the instant cisplatin treatment is initially mediated through the upregulation of β-catenin and activation of Wnt/β-catenin signaling pathway. As a result, a primary chemotherapeutic treatment with closely monitoring the targeted Wnt/β-catenin signaling pathway could potentially prevent the development of CSCs and improve the treatment efficiency in NPC.
鼻咽癌(NPC)是西方国家罕见的癌症之一,但在包括泰国在内的东南亚国家则较为常见。据报道,NPC 化疗失败的一个主要原因与癌症干细胞(CSC)分数的升高有关。因此,本研究旨在探讨顺铂(CDDP)治疗对 EBV 阴性 NPC 细胞中癌症干细胞样细胞(CSCs)富集及其相关信号通路的影响。通过用 0.5 μM 顺铂处理细胞 48 h 来首先生成顺铂预处理的 5-8F NPC 细胞(5-8F CDDP)。即时处理后,5-8F CDDP 显示出 IC 值增加,表明 CDDP 敏感性降低。此外,具有癌症干细胞样表型的 NPC 细胞的比例,包括侧群(SP)、关键的干细胞相关基因表达,包括 SOX2、ALDH1、CD24,显著增强。此外,5-8F CDDP 显示出β-连环蛋白基因的上调,表明其与 CSC 起始机制有关。此外,Wnt/β-连环蛋白通路的 tankyrase 抑制剂 XAV939 可显著减少 CSCs 并恢复 5-8F CDDP 中的顺铂敏感性。这证实了 Wnt/β-连环蛋白信号在 EBV 阴性 NPC 中 CSC 群体的增加是有原因的。最后,与单独使用 CDDP 相比,CDDP 和 XAV939 的联合治疗表现出较低的 5-8F CDDP 细胞活力,表明顺铂敏感性的逆转。总之,顺铂即时处理引起的 5-8F NPC 细胞中 CSCs 的增强最初是通过β-连环蛋白的上调和 Wnt/β-连环蛋白信号通路的激活介导的。因此,通过密切监测靶向 Wnt/β-连环蛋白信号通路进行初步化疗治疗可能有助于防止 CSCs 的发展并提高 NPC 的治疗效率。